tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MESO Stock Latest News

Mesoblast Touts Ryoncil Survival Data, Prepares Adult SR-aGvHD Pivotal Trial
Company AnnouncementsMesoblast Touts Ryoncil Survival Data, Prepares Adult SR-aGvHD Pivotal Trial
3d ago
6K
MESO
Mesoblast Lifts Ryoncil Revenues, Secures Cheaper Credit and Advances Late-Stage Cell Therapy Pipeline
PremiumCompany Announcements
Mesoblast Lifts Ryoncil Revenues, Secures Cheaper Credit and Advances Late-Stage Cell Therapy Pipeline
17d ago
6K
MESO
Mesoblast Reports 84% Survival in Early Real‑World Use of Ryoncil for Pediatric SR‑aGvHD
PremiumCompany Announcements
Mesoblast Reports 84% Survival in Early Real‑World Use of Ryoncil for Pediatric SR‑aGvHD
17d ago
6K
MESO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
18d ago
GDS
MMM
Mesoblast Wins FDA Backing on Pain and Opioid-Reduction Data for Rexlemestrocel-L in Chronic Low Back Pain
PremiumCompany Announcements
Mesoblast Wins FDA Backing on Pain and Opioid-Reduction Data for Rexlemestrocel-L in Chronic Low Back Pain
25d ago
6K
MESO
Mesoblast received FDA feedback on potential BLA for rexlemestrocel-L
PremiumThe FlyMesoblast received FDA feedback on potential BLA for rexlemestrocel-L
26d ago
MESO
Mesoblast Trims Option Overhang After Late-2025 Lapse of 1.45 Million Unquoted Options
Premium
Company Announcements
Mesoblast Trims Option Overhang After Late-2025 Lapse of 1.45 Million Unquoted Options
30d ago
6K
MESO
Mesoblast Expands Share Capital After Exercise of 6.9 Million Options
Premium
Company Announcements
Mesoblast Expands Share Capital After Exercise of 6.9 Million Options
1M ago
6K
MESO
Mesoblast Lapses 3 Million Unquoted Warrants, Slightly Simplifying Capital Structure
PremiumCompany Announcements
Mesoblast Lapses 3 Million Unquoted Warrants, Slightly Simplifying Capital Structure
1M ago
6K
MESO
Mesoblast chair Jane Bell to transition out of role, Philip Facchina to succeed
PremiumThe Fly
Mesoblast chair Jane Bell to transition out of role, Philip Facchina to succeed
1M ago
MESO
Mesoblast Issues 5 Million Unquoted Warrants as Fee for US$50 Million Convertible Note Facility
PremiumCompany Announcements
Mesoblast Issues 5 Million Unquoted Warrants as Fee for US$50 Million Convertible Note Facility
2M ago
6K
MESO
Mesoblast’s AGM Results: All Resolutions Passed on November 25, 2025
PremiumCompany Announcements
Mesoblast’s AGM Results: All Resolutions Passed on November 25, 2025
3M ago
6K
MESO
Mesoblast Achieves FDA Approval for Ryoncil®
PremiumCompany AnnouncementsMesoblast Achieves FDA Approval for Ryoncil®
3M ago
6K
MESO
Mesoblast upgraded to Buy at Jefferies as Ryoncil roll out continues
Premium
The Fly
Mesoblast upgraded to Buy at Jefferies as Ryoncil roll out continues
3M ago
MESO
Mesoblast upgraded to Buy from Hold at Jefferies
Premium
The Fly
Mesoblast upgraded to Buy from Hold at Jefferies
3M ago
MESO
Mesoblast to Launch Pivotal Ryoncil® Trial for Severe aGvHD in Adults
PremiumCompany Announcements
Mesoblast to Launch Pivotal Ryoncil® Trial for Severe aGvHD in Adults
3M ago
6K
MESO
Mesoblast collaborating with BMT CTN on trial of Ryoncil in acute GvHD
PremiumThe Fly
Mesoblast collaborating with BMT CTN on trial of Ryoncil in acute GvHD
3M ago
MESO
Mesoblast appoints James O’Brien as CFO
PremiumThe Fly
Mesoblast appoints James O’Brien as CFO
3M ago
ABBV
MESO
Mesoblast Announces Director’s Share Acquisition and New Equity Issuance
PremiumCompany Announcements
Mesoblast Announces Director’s Share Acquisition and New Equity Issuance
4M ago
6K
MESO
Mesoblast’s Promising Study on Chronic Low Back Pain Treatment: A Market Game Changer?
PremiumCompany AnnouncementsMesoblast’s Promising Study on Chronic Low Back Pain Treatment: A Market Game Changer?
4M ago
MESO
Mesoblast Reports Strong Revenue Growth with Ryoncil® Adoption
Premium
Company Announcements
Mesoblast Reports Strong Revenue Growth with Ryoncil® Adoption
4M ago
6K
MESO
Mesoblast reports Q2 Ryoncil revenue up 66% y/y
Premium
The Fly
Mesoblast reports Q2 Ryoncil revenue up 66% y/y
4M ago
MESO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >